Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...
Medindia5d
Tirzepatide: Combating Obesity, Kidney Disease, and Heart Failure Together
Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...
News-Medical.Net on MSN6d
Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...
Pharmaceutical Technology5d
ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
Physician's Weekly6d
Epicardial Fat and Heart Failure with Preserved Ejection Fraction
The following is a summary of "Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure ...
Healio6d
Tirzepatide improves outcomes in HFpEF, obesity regardless of kidney function
In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...
Managed Healthcare Executive6d
Positive Results for Tirzepatide in Those With the Cardiovascular-Kidney-Metabolic Triad | ACC 2025
Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...